[ Mon, Oct 16th 2023 ]: WOPRAI
[ Mon, Oct 16th 2023 ]: WOPRAI
[ Mon, Oct 16th 2023 ]: WOPRAI
[ Mon, Oct 16th 2023 ]: WOPRAI
[ Mon, Oct 16th 2023 ]: WOPRAI
[ Mon, Oct 16th 2023 ]: WOPRAI
[ Mon, Oct 16th 2023 ]: WOPRAI
[ Mon, Oct 16th 2023 ]: WOPRAI
[ Mon, Oct 16th 2023 ]: WOPRAI
[ Mon, Oct 16th 2023 ]: WOPRAI
[ Mon, Oct 16th 2023 ]: WOPRAI
[ Mon, Oct 16th 2023 ]: WOPRAI
[ Mon, Oct 16th 2023 ]: WOPRAI
[ Mon, Oct 16th 2023 ]: WOPRAI
[ Mon, Oct 16th 2023 ]: WOPRAI
[ Mon, Oct 16th 2023 ]: WOPRAI
[ Mon, Oct 16th 2023 ]: WOPRAI
[ Mon, Oct 16th 2023 ]: WOPRAI
[ Mon, Oct 16th 2023 ]: WOPRAI
[ Mon, Oct 16th 2023 ]: WOPRAI
[ Mon, Oct 16th 2023 ]: WOPRAI
[ Mon, Oct 16th 2023 ]: WOPRAI
[ Mon, Oct 16th 2023 ]: WOPRAI
[ Mon, Oct 16th 2023 ]: WOPRAI
[ Mon, Oct 16th 2023 ]: WOPRAI
[ Mon, Oct 16th 2023 ]: WOPRAI
[ Mon, Oct 16th 2023 ]: WOPRAI
[ Mon, Oct 16th 2023 ]: WOPRAI
[ Mon, Oct 16th 2023 ]: WOPRAI
[ Mon, Oct 16th 2023 ]: WOPRAI
[ Mon, Oct 16th 2023 ]: WOPRAI
[ Mon, Oct 16th 2023 ]: WOPRAI
[ Mon, Oct 16th 2023 ]: WOPRAI
[ Mon, Oct 16th 2023 ]: WOPRAI
[ Mon, Oct 16th 2023 ]: WOPRAI
[ Mon, Oct 16th 2023 ]: WOPRAI
[ Mon, Oct 16th 2023 ]: WOPRAI
[ Mon, Oct 16th 2023 ]: WOPRAI
[ Mon, Oct 16th 2023 ]: WOPRAI
[ Mon, Oct 16th 2023 ]: WOPRAI
[ Mon, Oct 16th 2023 ]: WOPRAI
[ Mon, Oct 16th 2023 ]: WOPRAI
[ Mon, Oct 16th 2023 ]: WOPRAI
[ Mon, Oct 16th 2023 ]: WOPRAI
[ Mon, Oct 16th 2023 ]: WOPRAI
[ Mon, Oct 16th 2023 ]: WOPRAI
[ Mon, Oct 16th 2023 ]: WOPRAI
[ Mon, Oct 16th 2023 ]: WOPRAI
David Westenberg Maintained (ADPT) at Buy with Decreased Target to $13 on, Oct 16th, 2023
- 🞛 This publication is a summary or evaluation of another publication
David Westenberg of Piper Sandler, Maintained "Adaptive Biotechnologies Corporation" (ADPT) at Buy with Decreased Target from $14 to $13 on, Oct 16th, 2023.
David has made no other calls on ADPT in the last 4 months.
There is 1 other peer that has a rating on ADPT. Out of the 1 peers that are also analyzing ADPT, all agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Tejas Savant of "Morgan Stanley" Maintained at Hold with Decreased Target to $13 on, Friday, August 4th, 2023